Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Avoiding barriers to PET radioligand development: cellular assays of brain efflux transporters.

× No keyword cloud information.

21 in total

Review 1. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.

Authors: Philip H Elsinga; N Harry Hendrikse; Joost Bart; Willem Vaalburg; Aren van Waarde
Journal: Curr Pharm Des Date: 2004 Impact factor: 3.116

2. Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY.

Authors: Jeih-San Liow; Shuiyu Lu; Julie A McCarron; Jinsoo Hong; John L Musachio; Victor W Pike; Robert B Innis; Sami S Zoghbi
Journal: Synapse Date: 2007-02 Impact factor: 2.562

3. In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically.

Authors: Kiichi Ishiwata; Kazunori Kawamura; Kazuhiko Yanai; N Harry Hendrikse
Journal: J Nucl Med Date: 2007-01 Impact factor: 10.057

Review 4. Blood-brain barrier permeability considerations for CNS-targeted compound library design.

Authors: Stephen A Hitchcock
Journal: Curr Opin Chem Biol Date: 2008-04-22 Impact factor: 8.822

Review 5. The role of the blood-CNS barrier in CNS disorders and their treatment.

Authors: Alan M Palmer
Journal: Neurobiol Dis Date: 2009-08-05 Impact factor: 5.996

6. Quantitative analysis of 11C-verapamil transfer at the human blood-brain barrier for evaluation of P-glycoprotein function.

Authors: Yoko Ikoma; Akihiro Takano; Hiroshi Ito; Hiroyuki Kusuhara; Yuichi Sugiyama; Ryosuke Arakawa; Toshimitsu Fukumura; Ryuji Nakao; Kazutoshi Suzuki; Tetsuya Suhara
Journal: J Nucl Med Date: 2006-09 Impact factor: 10.057

7. Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening.

Authors: Nicolas Tournier; Héric Valette; Marie-Anne Peyronneau; Wadad Saba; Sébastien Goutal; Bertrand Kuhnast; Frédéric Dollé; Jean-Michel Scherrmann; Salvatore Cisternino; Michel Bottlaender
Journal: J Nucl Med Date: 2011-02-14 Impact factor: 10.057

Review 8. Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications.

Authors: P Kannan; C John; S S Zoghbi; C Halldin; M M Gottesman; R B Innis; M D Hall
Journal: Clin Pharmacol Ther Date: 2009-07-22 Impact factor: 6.875

9. Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport.

Authors: Stina Syvänen; Orjan Lindhe; Mikael Palner; Birgitte R Kornum; Obaidur Rahman; Bengt Långström; Gitte M Knudsen; Margareta Hammarlund-Udenaes
Journal: Drug Metab Dispos Date: 2008-12-01 Impact factor: 3.922

Review 10. PET radiotracers: crossing the blood-brain barrier and surviving metabolism.

Authors: Victor W Pike
Journal: Trends Pharmacol Sci Date: 2009-07-16 Impact factor: 14.819

2 in total

1. Discrepancies in the P-glycoprotein-mediated transport of (18)F-MPPF: a pharmacokinetic study in mice and non-human primates.

Authors: Nicolas Tournier; Salvatore Cisternino; Marie-Anne Peyronneau; Sébastien Goutal; Frédéric Dolle; Jean-Michel Scherrmann; Michel Bottlaender; Wadad Saba; Héric Valette
Journal: Pharm Res Date: 2012-05-30 Impact factor: 4.200

2. Overlapping substrate and inhibitor specificity of human and murine ABCG2.

Authors: Joshua Bakhsheshian; Matthew D Hall; Robert W Robey; Michelle A Herrmann; Jin-Qiu Chen; Susan E Bates; Michael M Gottesman
Journal: Drug Metab Dispos Date: 2013-07-18 Impact factor: 3.922

2 in total